Pricing Log in Create free account

Definium Therapeutics, Inc. (DFTX) vs Travere Therapeutics, Inc. (TVTX)

Definium Therapeutics, Inc. and Travere Therapeutics, Inc. are both Biotechnology companies. Travere Therapeutics, Inc. is the larger, with a market value of $4.7B against $4.1B — 1.1× the size. Definium Therapeutics, Inc. has the higher net margin (0.00% vs −18.7%) and the higher return on invested capital (0.00% vs −54.1%). Across the 14 metrics below, Definium Therapeutics, Inc. leads on 8 and Travere Therapeutics, Inc. on 6.

Valuation

Metric DFTX TVTX Biotechnology median
P/E n/m n/m 10.60
P/S n/m 7.19 9.40
P/B 4.01 207.20 2.13
Price to free cash flow n/m 55.27 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 7.39 9.02
Earnings yield (10.31%) (2.61%) (32.88%)
Free cash flow yield (4.56%) 1.81% (23.13%)

Profitability

Metric DFTX TVTX Biotechnology median
Gross margin 0.00% 98.53% 68.51%
Operating margin 0.00% (20.51%) 0.00%
Net margin 0.00% (18.66%) 0.00%
Free cash flow margin 0.00% 13.11% 0.00%
Return on equity (64.09%) (252.75%) (51.96%)
Return on assets (51.35%) (17.52%) (46.06%)
Return on invested capital 0.00% (54.08%) 0.00%

Growth

Metric DFTX TVTX Biotechnology median
Revenue growth (TTM) — 49.38% 6.76%
EPS growth (last fiscal year) (33.77%) 92.89% 29.88%
Revenue growth, 5-year CAGR — 19.87% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DFTX TVTX Biotechnology median
Debt to equity 0.04 26.72 0.00
Current ratio 6.95 3.00 4.97
Net debt to EBITDA 2.21 2.27 1.01

Dividend

Metric DFTX TVTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DFTX TVTX Biotechnology median
Market cap 4.08b 4.69b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack